Top Pharma Companies & Drugs in 2024: Merck’s Keytruda maintains top spot as Novo’s semaglutide nips at its heels

Data Compilation
#PharmaFlow

Pipeline Prospector March 2025: Trump’s FDA overhaul spooks biotech stocks; Roche, AbbVie, Novo ink obesity drug deals

Stock Recap
#PipelineProspector

ADENOCARD

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 21 USDMF, 4 CEP/COS, 1 EU WC, 3 NDC API, 10 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

58 FDF Dossiers, 33 FDA Orange Book, 5 Europe, 4 Canada, 2 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;INTRAVENOUS - 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 11 Evonik, 7 Rochem International Inc, 14 SPI Pharma, 22 DKSH, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 3 Gangwal Healthcare, 2 Kewpie Corporation, 24 Nanjing Well Pharmaceutical, 4 Pfanstiehl, 1 Capital Farma, 4 ACG Worldwide, 11 Actylis, 2 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 20 BASF, 1 Bioplus Life Sciences, 2 BioSpectra, 2 Clariant, 16 Corel Pharma Chem, 4 Finar, 16 Gangwal Chemicals, 2 Hayashibara, 4 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 18 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 6 Lubrizol Life Science Health, 12 Microlex e.U, 4 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 1 Novo Excipients, 5 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 31 Roquette, 28 Seppic, 3 Shandong Focus Biotechnology Co., Ltd, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 3 Sigachi Industries, 1 Symrise, 3 The Dow Chemical Company, 1 TopChem Pharmaceuticals, 2 Valens Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

86 Topical, 66 Solubilizers, 57 Thickeners and Stabilizers, 50 Coating Systems & Additives, 39 Fillers, Diluents & Binders, 39 Emulsifying Agents, 36 Parenteral, 26 Film Formers & Plasticizers, 26 Taste Masking, 24 Surfactant & Foaming Agents, 20 Controlled & Modified Release, 16 Rheology Modifiers, 14 Co-Processed Excipients, 14 Direct Compression, 12 Lubricants & Glidants, 11 Chewable & Orodispersible Aids, 10 API Stability Enhancers, 10 Granulation, 9 Empty Capsules, 7 Disintegrants & Superdisintegrants, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

15 News #PharmaBuzz

15 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

20 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
25/04/2025	Actylis	U.S.A	PHARMA-WALDHOF GMBH	7728	ADENOSINE	1988-10-25	Active	II	Complete	2013-06-08	2013-05-30
25/04/2025	Actylis	U.S.A	PHARMA-WALDHOF GMBH	8713	N6-(2-ISOPENTENYL)-ADENOSINE	1990-08-17	Inactive	II	N/A

ADENOCARD

ADENOCARD

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers

21 USDMF

4 CEP/COS

1 EU WC

3 NDC API

10 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

58 FDF Dossiers

33 FDA Orange Book

5 Europe

4 Canada

2 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;INTRAVENOUS - 90MG/30ML (3MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

11 Evonik

7 Rochem International Inc

14 SPI Pharma

22 DKSH

1 Pharm-RX Chemical

4 Faran Shimi Pharmaceutical

3 Gangwal Healthcare

2 Kewpie Corporation

24 Nanjing Well Pharmaceutical

4 Pfanstiehl

1 Capital Farma

4 ACG Worldwide

11 Actylis

2 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

20 BASF

1 Bioplus Life Sciences

2 BioSpectra

2 Clariant

16 Corel Pharma Chem

4 Finar

16 Gangwal Chemicals

2 Hayashibara

4 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

18 Kerry

4 Kima Chemical

6 Lonza Capsugel

6 Lubrizol Life Science Health

12 Microlex e.U

4 Nanjing Bold Chemical

2 Nippon Fine Chemical

1 Novo Excipients

5 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

31 Roquette

28 Seppic

3 Shandong Focus Biotechnology Co., Ltd

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

3 Sigachi Industries

1 Symrise

3 The Dow Chemical Company

1 TopChem Pharmaceuticals

2 Valens Pharmachem

1 Vertellus

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

86 Topical

66 Solubilizers

57 Thickeners and Stabilizers

INJECTABLE;INJECTION - 3MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 60MG/20ML (3MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 90MG/30ML (3MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons